Tirupati-based Mohan Babu University’s School of Pharmaceutical Sciences bags three-start MHRD IIC rankings
The accomplishment propels SVCP into the esteemed league of India’s top 100 pharmacy institutes, signifying a monumental leap in its academic journey
Mohan Babu University’s School of Pharmaceutical Sciences, formerly known as Sree Vidyanikethan College of Pharmacy (SVCP), proudly announces its remarkable achievement in securing a coveted 3-star rating in the Ministry of Human Resource Development (MHRD) Innovation Council (IIC) Rankings for the year 2023. This accomplishment propels SVCP into the esteemed league of India’s top 100 pharmacy institutes, signifying a monumental leap in its academic journey.
The Ministry of Human Resource Development, Government of India, officially declared SVCP’s 3-star rating, recognising the institution’s relentless commitment to fostering innovation and academic excellence.
This extraordinary milestone solidifies SVCP’s position as a trailblazer in the realm of pharmacy education, showcasing its dedication to nurturing a culture of innovation and entrepreneurial prowess. SVCP’s elevation from its prior standing to securing a three-star rating underscores its unwavering commitment to advancement and sets a new benchmark for academic brilliance.
Affiliated with Jawaharlal Nehru Technological University, Anantapur, Anantapuramu, MBUs School of Pharmaceutical Sciences, formerly known as Sree Vidyanikethan College of Pharmacy (SVCP) offers comprehensive programs including Pharm.D, B.Pharm, and M.Pharm courses, supported by an esteemed faculty and a vibrant student community. Mohan Babu University’s College of Pharmacy continuously strives to empower students with a dynamic learning environment that encourages exploration, creativity, and transformative thinking.
This achievement in the MHRD IIC Rankings serves as a testament to SVCP’s relentless pursuit of excellence in education, research, and innovation. The institution remains steadfast in its mission to drive impactful change and inspire the next generation of pharmaceutical leaders.
